RYTM — Rhythm Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $6.06bn
- $5.83bn
- $189.76m
Rhythm's drug shows promise for brain tumor-related weight condition in small study (updated)
Rhythm Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition
Rhythm Pharmaceuticals Q2 net loss narrows on US launch demand
U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation
Brief: Rhythm Pharmaceuticals Announces Multiple New Data Presentations From Mc4r Agonists
Brief: Rhythm Pharmaceuticals Says Six-Month Data Shows Setmelanotide Improves Multiple Endpoints In Pws
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
Rhythm Pharmaceuticals gains on Q1 revenue growth
Rhythm Pharmaceuticals Q1 revenue rises 84%
Brief: Rhythm Pharmaceuticals Q1 Net Income USD -55.639 Million Vs. IBES Estimate USD -55.3 Million
Brief: Rhythm Pharmaceuticals Announces New Data Presentations In Acquired Hypothalamic Obesity At Pediatric Endocrine Society
U.S. STOCKS ON THE MOVE-Perella Weinberg Partners, Amkor Technology, Esperion Therapeutics
U.S. STOCKS ON THE MOVE-Paramount Skydance, Newell Brands, Rhythm,
Rhythm rises after European Commission approves drug for rare form of obesity
U.S. STOCKS ON THE MOVE -Flowco Holdings, Unusual Machines, Insperity
U.S. STOCKS ON THE MOVE-SolarEdge, Mosaic, Dell
U.S. STOCKS ON THE MOVE-Unilever, Janus, Arm Holdings